1BQM - Header Asymmetric Unit

HEADER NUCLEOTIDYLTRANSFERASE 17-AUG-98 1BQM

TITLE HIV-1 RT/HBY 097

COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HIV-1 RT; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: REVERSE TRANSCRIPTASE; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: HIV-1 RT; COMPND 12 EC: 2.7.7.49; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: BH10; SOURCE 5 CELL_LINE: 293; SOURCE 6 ATCC: ATCC 1065288; SOURCE 7 COLLECTION: ATCC 1065288; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: 293; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 13 ORGANISM_TAXID: 11676; SOURCE 14 STRAIN: BH10; SOURCE 15 CELL_LINE: 293; SOURCE 16 COLLECTION: ATCC 1065288; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: 293

KEYWDS NUCLEOTIDYLTRANSFERASE, AIDS, RNA-DIRECTED DNA POLYMERASE, KEYWDS 2 HIV-1 RT/HBY 097, DRUG-RESISTANT MUTANT

EXPDTA X-RAY DIFFRACTION

AUTHOR Y.HSIOU,K.DAS,J.DING,E.ARNOLD

REVDAT 4 24-FEB-09 1BQM 1 VERSN REVDAT 3 01-APR-03 1BQM 1 JRNL REVDAT 2 16-FEB-99 1BQM 3 HET SOURCE COMPND REMARK REVDAT 2 2 3 HETATM DBREF JRNL HETSYN REVDAT 1 06-JAN-99 1BQM 0

JRNL AUTH Y.HSIOU,K.DAS,J.DING,A.D.CLARK JR.,J.P.KLEIM, JRNL AUTH 2 M.ROSNER,I.WINKLER,G.RIESS,S.H.HUGHES,E.ARNOLD JRNL TITL STRUCTURES OF TYR188LEU MUTANT AND WILD-TYPE HIV-1 JRNL TITL 2 REVERSE TRANSCRIPTASE COMPLEXED WITH THE JRNL TITL 3 NON-NUCLEOSIDE INHIBITOR HBY 097: INHIBITOR JRNL TITL 4 FLEXIBILITY IS A USEFUL DESIGN FEATURE FOR JRNL TITL 5 REDUCING DRUG RESISTANCE. JRNL REF J.MOL.BIOL. V. 284 313 1998 JRNL REFN ISSN 0022-2836 JRNL PMID 9813120 JRNL DOI 10.1006/JMBI.1998.2171

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.DAS,J.DING,Y.HSIOU,A.D.CLARK JUNIOR,H.MOEREELS, REMARK 1 AUTH 2 L.KOYMANS,K.ANDRIES,R.PAUWELS,P.A.JANSSEN, REMARK 1 AUTH 3 P.L.BOYER,P.CLARK,R.H.SMITH JUNIOR, REMARK 1 AUTH 4 M.B.KROEGER SMITH,C.J.MICHEJDA,S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURES OF 8-CL AND 9-CL TIBO COMPLEXED REMARK 1 TITL 2 WITH WILD-TYPE HIV-1 RT AND 8-CL TIBO COMPLEXED REMARK 1 TITL 3 WITH THE TYR181CYS HIV-1 RT DRUG-RESISTANT MUTANT REMARK 1 REF J.MOL.BIOL. V. 264 1085 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.ARNOLD,K.DAS,J.DING,P.N.YADAV,Y.HSIOU,P.L.BOYER, REMARK 1 AUTH 2 S.H.HUGHES REMARK 1 TITL TARGETING HIV REVERSE TRANSCRIPTASE FOR ANTI-AIDS REMARK 1 TITL 2 DRUG DESIGN: STRUCTURAL AND BIOLOGICAL REMARK 1 TITL 3 CONSIDERATIONS FOR CHEMOTHERAPEUTIC STRATEGIES REMARK 1 REF DRUG DES.DISCOVERY V. 13 29 1996 REMARK 1 REFN ISSN 1055-9612 REMARK 1 REFERENCE 3 REMARK 1 AUTH Y.HSIOU,J.DING,K.DAS,A.D.CLARK JUNIOR,S.H.HUGHES, REMARK 1 AUTH 2 E.ARNOLD REMARK 1 TITL STRUCTURE OF UNLIGANDED HIV-1 REVERSE REMARK 1 TITL 2 TRANSCRIPTASE AT 2.7 A RESOLUTION: IMPLICATIONS OF REMARK 1 TITL 3 CONFORMATIONAL CHANGES FOR POLYMERIZATION AND REMARK 1 TITL 4 INHIBITION MECHANISMS REMARK 1 REF STRUCTURE V. 4 853 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.DING,K.DAS,C.TANTILLO,W.ZHANG,A.D.CLARK JUNIOR, REMARK 1 AUTH 2 S.JESSEN,X.LU,Y.HSIOU,A.JACOBO-MOLINA,K.ANDRIES, REMARK 1 AUTH 3 R.PAUWELS,H.MOEREELS,L.KOYMANS,P.A.J.JANSSEN, REMARK 1 AUTH 4 R.H.SMITH JUNIOR,M.KROEGER KOEPKE,C.J.MICHEJDA, REMARK 1 AUTH 5 S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A REMARK 1 TITL 2 COMPLEX WITH THE NON-NUCLEOSIDE INHIBITOR REMARK 1 TITL 3 ALPHA-APA R 95845 AT 2.8 A RESOLUTION REMARK 1 REF STRUCTURE V. 3 365 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 5 REMARK 1 AUTH J.DING,K.DAS,H.MOEREELS,L.KOYMANS,K.ANDRIES, REMARK 1 AUTH 2 P.A.JANSSEN,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 RT/TIBO R 86183 COMPLEX REVEALS REMARK 1 TITL 2 SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE REMARK 1 TITL 3 INHIBITORS REMARK 1 REF NAT.STRUCT.BIOL. V. 2 407 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 6 REMARK 1 AUTH C.TANTILLO,J.DING,A.JACOBO-MOLINA,R.G.NANNI, REMARK 1 AUTH 2 P.L.BOYER,S.H.HUGHES,R.PAUWELS,K.ANDRIES, REMARK 1 AUTH 3 P.A.JANSSEN,E.ARNOLD REMARK 1 TITL LOCATIONS OF ANTI-AIDS DRUG BINDING SITES AND REMARK 1 TITL 2 RESISTANCE MUTATIONS IN THE THREE-DIMENSIONAL REMARK 1 TITL 3 STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE. REMARK 1 TITL 4 IMPLICATIONS FOR MECHANISMS OF DRUG INHIBITION AND REMARK 1 TITL 5 RESISTANCE REMARK 1 REF J.MOL.BIOL. V. 243 369 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 7 REMARK 1 AUTH A.JACOBO-MOLINA,J.DING,R.G.NANNI,A.D.CLARK JUNIOR, REMARK 1 AUTH 2 X.LU,C.TANTILLO,R.L.WILLIAMS,G.KAMER,A.L.FERRIS, REMARK 1 AUTH 3 P.CLARK,A.HIZI,S.H.HUGHES,E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS REMARK 1 TITL 2 TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH REMARK 1 TITL 3 DOUBLE-STRANDED DNA AT 3.0 A RESOLUTION SHOWS BENT REMARK 1 TITL 4 DNA REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 6320 1993 REMARK 1 REFN ISSN 0027-8424

REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.85 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 10.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 22627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.258 REMARK 3 FREE R VALUE : 0.362 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1802 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.24 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1736 REMARK 3 BIN R VALUE (WORKING SET) : 0.3490 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 100 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7804 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 98.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.51 REMARK 3 ESD FROM SIGMAA (A) : 0.61 REMARK 3 LOW RESOLUTION CUTOFF (A) : 10.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.71 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.68 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.59 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.570 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.820 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.640 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.680 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAM19X.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 PARAMETER FILE 3 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1BQM COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAR-95 REMARK 200 TEMPERATURE (KELVIN) : 108 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : WIGGLERS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : PRINCETON 2K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30368 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.89000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.85 REMARK 200 STARTING MODEL: PDB ENTRY 1TVR REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.8

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 112.60000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 112.60000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 47470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 24 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 24 CZ3 CH2 REMARK 470 LEU A 26 CG CD1 CD2 REMARK 470 THR A 27 OG1 CG2 REMARK 470 ILE A 63 CG1 CG2 CD1 REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 ASP A 67 CG OD1 OD2 REMARK 470 LYS A 70 CG CD CE NZ REMARK 470 TRP A 71 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 71 CZ3 CH2 REMARK 470 ARG A 72 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 91 CG CD OE1 NE2 REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 THR A 139 OG1 CG2 REMARK 470 ASP A 218 CG OD1 OD2 REMARK 470 LYS A 219 CG CD CE NZ REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 HIS A 221 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 222 CG CD OE1 NE2 REMARK 470 GLU A 233 CG CD OE1 OE2 REMARK 470 GLU A 248 CG CD OE1 OE2 REMARK 470 ARG A 277 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 THR A 286 OG1 CG2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 VAL A 292 CG1 CG2 REMARK 470 ILE A 293 CG1 CG2 CD1 REMARK 470 GLU A 297 CG CD OE1 OE2 REMARK 470 LEU A 301 CG CD1 CD2 REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 LYS A 323 CG CD CE NZ REMARK 470 GLU A 328 CG CD OE1 OE2 REMARK 470 GLN A 334 CG CD OE1 NE2 REMARK 470 GLN A 336 CG CD OE1 NE2 REMARK 470 LYS A 347 CG CD CE NZ REMARK 470 ARG A 356 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 366 CG CD CE NZ REMARK 470 ILE A 411 CG1 CG2 CD1 REMARK 470 LYS A 424 CG CD CE NZ REMARK 470 ASN A 447 CG OD1 ND2 REMARK 470 LYS A 451 CG CD CE NZ REMARK 470 GLU A 514 CG CD OE1 OE2 REMARK 470 GLU A 529 CG CD OE1 OE2 REMARK 470 ILE A 542 CG1 CG2 CD1 REMARK 470 GLU A 546 CG CD OE1 OE2 REMARK 470 LYS A 550 CG CD CE NZ REMARK 470 ILE A 556 CG1 CG2 CD1 REMARK 470 PRO B 1 CB REMARK 470 LYS B 66 CG CD CE NZ REMARK 470 LYS B 70 CG CD CE NZ REMARK 470 ASP B 121 CG OD1 OD2 REMARK 470 GLN B 174 CG CD OE1 NE2 REMARK 470 HIS B 221 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 222 CG CD OE1 NE2 REMARK 470 TRP B 229 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 229 CZ3 CH2 REMARK 470 MET B 230 CG SD CE REMARK 470 ASP B 237 CG OD1 OD2 REMARK 470 VAL B 241 CG1 CG2 REMARK 470 GLN B 242 CG CD OE1 NE2 REMARK 470 LYS B 249 CG CD CE NZ REMARK 470 ASP B 250 CG OD1 OD2 REMARK 470 GLN B 278 CG CD OE1 NE2 REMARK 470 LYS B 281 CG CD CE NZ REMARK 470 LEU B 283 CG CD1 CD2 REMARK 470 ARG B 284 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 291 CG CD OE1 OE2 REMARK 470 GLU B 305 CG CD OE1 OE2 REMARK 470 LEU B 310 CG CD1 CD2 REMARK 470 GLU B 312 CG CD OE1 OE2 REMARK 470 LYS B 323 CG CD CE NZ REMARK 470 MET B 357 CG SD CE REMARK 470 ARG B 358 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 361 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 422 CG CD1 CD2 REMARK 470 TYR B 427 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN B 428 CG CD OE1 NE2

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 4 40.86 -100.71 REMARK 500 VAL A 21 -148.82 -137.60 REMARK 500 LYS A 22 119.25 179.61 REMARK 500 TRP A 24 96.57 -56.79 REMARK 500 PRO A 25 117.86 -38.84 REMARK 500 GLU A 28 -81.83 -8.21 REMARK 500 GLU A 53 -4.05 70.73 REMARK 500 TYR A 56 -162.52 -76.17 REMARK 500 ASN A 57 175.61 172.84 REMARK 500 ALA A 62 54.10 -94.80 REMARK 500 LYS A 66 -73.91 71.06 REMARK 500 ASP A 67 62.90 159.16 REMARK 500 LEU A 74 116.44 -165.25 REMARK 500 LYS A 104 -80.97 15.94 REMARK 500 VAL A 111 51.56 -95.91 REMARK 500 ASP A 113 50.68 -107.06 REMARK 500 TRP A 153 111.30 -10.60 REMARK 500 LYS A 154 -58.78 -22.49 REMARK 500 SER A 156 -73.27 -45.69 REMARK 500 GLN A 161 -4.78 -57.98 REMARK 500 ASP A 177 -1.62 66.12 REMARK 500 ILE A 178 41.29 -107.56 REMARK 500 VAL A 179 127.10 -20.28 REMARK 500 MET A 184 -83.76 57.64 REMARK 500 ASP A 192 58.81 -111.95 REMARK 500 ILE A 195 -56.97 3.19 REMARK 500 PRO A 217 39.28 -73.25 REMARK 500 LYS A 219 93.77 -14.84 REMARK 500 GLN A 222 63.88 -51.49 REMARK 500 PRO A 236 3.93 -51.50 REMARK 500 ASP A 237 5.09 -153.18 REMARK 500 THR A 240 -174.50 178.77 REMARK 500 GLN A 242 -73.68 -77.94 REMARK 500 ILE A 244 57.52 -153.49 REMARK 500 LYS A 249 -156.76 -132.68 REMARK 500 SER A 251 71.15 -168.65 REMARK 500 TYR A 271 94.70 -56.02 REMARK 500 PRO A 272 109.05 -47.28 REMARK 500 ILE A 274 144.35 -170.18 REMARK 500 ARG A 277 -71.26 -62.63 REMARK 500 THR A 286 34.28 -75.24 REMARK 500 LYS A 287 -154.92 -67.13 REMARK 500 LEU A 289 46.95 -82.54 REMARK 500 THR A 290 -16.81 -146.55 REMARK 500 PRO A 294 94.51 -68.36 REMARK 500 ARG A 307 -19.27 -46.49 REMARK 500 LYS A 311 -73.90 -59.45 REMARK 500 PRO A 313 154.02 -43.10 REMARK 500 ASP A 324 172.27 -42.66 REMARK 500 GLN A 343 -71.75 -111.82 REMARK 500 PRO A 345 148.17 -24.80 REMARK 500 PHE A 346 -58.97 60.84 REMARK 500 ALA A 360 -157.85 -71.14 REMARK 500 HIS A 361 10.55 57.59 REMARK 500 ILE A 382 -67.72 -106.41 REMARK 500 GLU A 399 1.73 -68.61 REMARK 500 TRP A 401 45.73 -149.96 REMARK 500 TRP A 402 -50.85 -150.18 REMARK 500 TRP A 410 111.07 -161.59 REMARK 500 PRO A 412 -141.40 -57.54 REMARK 500 GLN A 428 131.94 -173.50 REMARK 500 LYS A 451 62.66 34.10 REMARK 500 ALA A 455 -160.15 -102.48 REMARK 500 LYS A 465 152.41 175.30 REMARK 500 ASP A 488 34.26 -95.05 REMARK 500 PRO A 510 -160.14 -72.59 REMARK 500 ASP A 511 -45.43 -157.86 REMARK 500 GLU A 529 -86.29 -82.16 REMARK 500 HIS A 539 19.25 57.83 REMARK 500 LYS A 540 21.14 -143.04 REMARK 500 ILE B 5 -144.86 -104.64 REMARK 500 PRO B 14 85.64 -18.61 REMARK 500 THR B 27 176.62 -58.10 REMARK 500 THR B 58 128.63 177.45 REMARK 500 PHE B 61 -164.86 -118.01 REMARK 500 LYS B 66 -82.36 65.35 REMARK 500 THR B 69 -56.57 -172.82 REMARK 500 ASP B 76 78.33 -69.15 REMARK 500 ARG B 83 -88.24 -80.05 REMARK 500 GLN B 85 12.11 -69.29 REMARK 500 VAL B 90 -70.36 -120.86 REMARK 500 PRO B 97 88.07 -68.12 REMARK 500 ALA B 98 33.46 -64.75 REMARK 500 LYS B 104 -34.51 -16.92 REMARK 500 VAL B 111 54.42 -94.14 REMARK 500 PHE B 116 8.96 -57.96 REMARK 500 GLU B 122 -39.06 -38.70 REMARK 500 ARG B 125 -35.75 -30.11 REMARK 500 ASN B 136 38.88 39.31 REMARK 500 ASN B 137 28.02 43.55 REMARK 500 GLU B 138 -83.11 -62.72 REMARK 500 VAL B 148 -159.76 -98.24 REMARK 500 TRP B 153 139.61 -29.17 REMARK 500 SER B 156 -62.63 -100.32 REMARK 500 MET B 184 -129.12 55.89 REMARK 500 ILE B 195 -70.50 -40.68 REMARK 500 TRP B 212 19.46 -61.20 REMARK 500 GLN B 222 164.58 166.38 REMARK 500 PHE B 227 103.20 -57.49 REMARK 500 TRP B 229 -73.92 -69.89 REMARK 500 MET B 230 -89.68 -72.75 REMARK 500 PRO B 236 5.30 -56.75 REMARK 500 GLN B 242 64.63 -156.57 REMARK 500 ILE B 244 87.80 -57.74 REMARK 500 SER B 251 19.19 -175.30 REMARK 500 THR B 253 -169.12 -111.32 REMARK 500 ALA B 267 10.65 -63.24 REMARK 500 VAL B 292 91.55 -64.25 REMARK 500 GLU B 312 101.39 -169.85 REMARK 500 VAL B 314 -78.61 -127.61 REMARK 500 VAL B 317 89.20 -47.44 REMARK 500 TYR B 342 -161.22 -117.48 REMARK 500 GLN B 343 -27.41 -155.16 REMARK 500 PRO B 345 126.92 -20.79 REMARK 500 PHE B 346 -14.09 83.73 REMARK 500 LYS B 350 128.90 -175.58 REMARK 500 ARG B 356 170.16 158.29 REMARK 500 ALA B 360 -150.54 -95.33 REMARK 500 THR B 362 29.43 45.77 REMARK 500 THR B 403 -0.40 -52.69 REMARK 500 LYS B 424 41.43 -89.03 REMARK 500 TRP B 426 -27.36 -148.15 REMARK 500 TYR B 427 137.80 160.75 REMARK 500 REMARK 500 REMARK: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBY A 557

DBREF 1BQM A 1 556 UNP P03366 POL_HV1B1 599 1154 DBREF 1BQM B 1 430 UNP P03366 POL_HV1B1 599 1028

SEQADV 1BQM SER A 280 UNP P03366 CYS 447 ENGINEERED SEQADV 1BQM SER B 280 UNP P03366 CYS 447 ENGINEERED

SEQRES 1 A 556 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 556 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 556 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 556 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 556 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 556 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 556 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 556 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 556 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 556 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 556 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 556 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 556 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 556 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 556 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 556 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 556 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 556 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 556 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 556 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 556 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 556 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 A 556 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 556 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 556 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 556 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 556 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 556 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 556 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 556 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 556 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 556 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 556 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 556 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 556 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 556 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 556 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 556 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 556 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 556 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 556 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 556 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 556 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE SEQRES 1 B 430 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 430 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 430 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 430 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 430 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 430 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 430 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 430 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 430 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 430 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 430 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 430 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 430 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 430 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 430 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 430 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 430 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 430 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 430 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 430 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 430 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 430 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 430 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 430 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 430 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 430 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 430 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 430 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 430 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 430 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 430 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 430 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 430 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 430 GLU

HET HBY A 557 22

HETNAM HBY (S)-4-ISOPROPOXYCARBONYL-6-METHOXY-3-METHYLTHIOMETHYL- HETNAM 2 HBY 3,4-DIHYDROQUINOXALIN-2(1H)-THIONE

HETSYN HBY HBY 097

FORMUL 3 HBY C15 H20 N2 O3 S2

HELIX 1 AA GLU A 28 GLU A 44 1 17 HELIX 2 AB ARG A 78 ARG A 83 1 6 HELIX 3 AC ALA A 114 SER A 117 1 4 HELIX 4 AD GLU A 122 TYR A 127 1 6 HELIX 5 AE LYS A 154 GLN A 174 1 21 HELIX 6 AF ILE A 195 TRP A 212 1 18 HELIX 7 AH VAL A 254 GLN A 269 1 16 HELIX 8 AI ARG A 277 LEU A 283 1 7 HELIX 9 AJ GLU A 297 LYS A 311 1 15 HELIX 10 AK ASP A 364 TRP A 383 1 20 HELIX 11 AL LYS A 395 GLU A 404 1 10 HELIX 12 A' ASN A 474 ASP A 488 1 15 HELIX 13 B' GLN A 500 ALA A 508 1 9 HELIX 14 D' GLU A 516 LYS A 527 1 12 HELIX 15 E' GLY A 544 ALA A 554 1 11 HELIX 16 BA GLU B 28 GLU B 44 1 17 HELIX 17 BB ARG B 78 VAL B 90 1 13 HELIX 18 BC GLY B 112 SER B 117 1 6 HELIX 19 BD GLU B 122 THR B 128 1 7 HELIX 20 BE LYS B 154 GLN B 174 1 21 HELIX 21 BF ILE B 195 TRP B 212 1 18 HELIX 22 BH VAL B 254 ILE B 270 1 17 HELIX 23 BI ARG B 277 LEU B 283 1 7 HELIX 24 BJ GLU B 297 LYS B 311 1 15 HELIX 25 BK ASP B 364 TRP B 383 1 20 HELIX 26 BL LYS B 395 TYR B 405 1 11

SHEET 1 S1 3 ILE A 47 ILE A 50 0 SHEET 2 S1 3 ILE A 142 TYR A 146 -1 SHEET 3 S1 3 THR A 128 ILE A 132 -1 SHEET 1 S2 2 ASN A 57 LYS A 64 0 SHEET 2 S2 2 ARG A 72 PHE A 77 -1 SHEET 1 S3 3 SER A 105 VAL A 111 0 SHEET 2 S3 3 ASP A 186 SER A 191 -1 SHEET 3 S3 3 ILE A 178 TYR A 183 -1 SHEET 1 S4 4 PHE A 227 TRP A 229 0 SHEET 2 S4 4 TYR A 232 HIS A 235 -1 SHEET 3 S4 4 LYS A 238 VAL A 241 -1 SHEET 4 S4 4 VAL A 314 ASP A 320 -1 SHEET 1 S5 5 LYS A 347 ARG A 356 0 SHEET 2 S5 5 GLN A 336 TYR A 342 -1 SHEET 3 S5 5 LEU A 325 GLN A 332 -1 SHEET 4 S5 5 PRO A 387 LEU A 391 1 SHEET 5 S5 5 GLU A 413 THR A 419 1 SHEET 1 S6 5 GLY A 462 THR A 470 0 SHEET 2 S6 5 LEU A 452 THR A 459 -1 SHEET 3 S6 5 GLU A 438 ASN A 447 -1 SHEET 4 S6 5 GLU A 492 THR A 497 1 SHEET 5 S6 5 LYS A 530 VAL A 536 1 SHEET 1 S7 3 ILE B 47 GLY B 51 0 SHEET 2 S7 3 ILE B 142 TYR B 146 -1 SHEET 3 S7 3 ALA B 129 ILE B 132 -1 SHEET 1 S8 2 TYR B 56 LYS B 64 0 SHEET 2 S8 2 TRP B 71 ASP B 76 -1 SHEET 1 S9 3 SER B 105 ASP B 110 0 SHEET 2 S9 3 ASP B 186 SER B 191 -1 SHEET 3 S9 3 ILE B 178 TYR B 183 -1 SHEET 1 S10 5 LYS B 347 ARG B 356 0 SHEET 2 S10 5 GLN B 336 TYR B 342 -1 SHEET 3 S10 5 LEU B 325 LYS B 331 -1 SHEET 4 S10 5 PRO B 387 LEU B 391 1 SHEET 5 S10 5 GLU B 413 VAL B 417 1

SITE 1 AC1 12 PRO A 95 LEU A 100 LYS A 101 VAL A 179 SITE 2 AC1 12 TYR A 188 VAL A 189 GLY A 190 PRO A 225 SITE 3 AC1 12 PHE A 227 TRP A 229 LEU A 234 TYR A 318

CRYST1 225.200 69.400 104.600 90.00 106.40 90.00 C 1 2 1 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.004440 0.000000 0.001307 0.00000

SCALE2 0.000000 0.014409 0.000000 0.00000

SCALE3 0.000000 0.000000 0.009966 0.00000